Chitosan mediated targeted drug delivery system: A review

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 4, 2010, Pages 536-557

  Patel, Manish P ^a   Patel, Ravi R ^a   Patel, Jayvadan K ^a  

^a NOOTAN PHARMACY COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; CHITOSAN; CHITOSAN DERIVATIVE; DIAMMONIUM GLYCYRRHIZINATE; DICLOFENAC; DOXORUBICIN; EUDRAGIT; FLUOROURACIL; GLYCYRRHIZIC ACID; LOW MOLECULAR WEIGHT CHITOSIN; METRONIDAZOLE; MICROSPHERE; NANOPARTICLE; OXANTHRAZOLE; PACLITAXEL; POLYELECTROLYTE; POLYGLACTIN; PREDNISOLONE; PRODRUG; RETINOIC ACID; SELF ASSEMBLED CHITOSAN NANOPARTICLE; UNCLASSIFIED DRUG;

BRAIN TUMOR; CHEMICAL MODIFICATION; CHRONIC HEPATITIS; CLINICAL TRIAL; COLITIS; COLON TUMOR; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG SPECIFICITY; DRUG TARGETING; ENDOCYTOSIS; ENDOSOME; EPITHELIUM TUMOR; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; INTESTINE TRANSIT TIME; LIVER CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAGNETISM; MEAN RESIDENCE TIME; MICROENCAPSULATION; MOLECULARLY TARGETED THERAPY; NANOENCAPSULATION; NONHUMAN; REVIEW; SUSTAINED DRUG RELEASE;

EID: 78650342641     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3jc7c     Document Type: Review

References (145)

1. J.A. DiMasi, R.W. Hansen, H.G. Grabowski, The price of innovation: new estimates of drug development costs, J. Health Econ. 22 (2003) 151-185.
2. R. Langer, Drug delivery and targeting, Nature 392 (1998) 5-10.
3. G. Poste, R. Kirsh, Site-specific(targeted) drug delivery in cancer therapy, Biotechnology 1 (1983) 869-878.
4. G. Gregoriadis, Targeting of drugs, Nature 265 (1977) 407-411.
5. K. Strebhardt, A. Ullrich, Paul Ehrlich's magic bullet concept: 100 years of progress, Nat. Rev. Cancer 8 (2008) 473-480.
6. J.K. Vasir, M.K. Reddy, V.D. Labhasetwar, Nanosystems in drug targeting: opportunities and challenges, Curr. Nanosci. 1 (2005) 47-64.
7. R. Duncan, The dawning era of polymer therapeutics, Nat. Rev. Drug Discov. 2 (2003) 347-360.
8. R. Duncan, Polymer conjugates for drug targeting. Frominspired to inspiration! J.Drug Target 14 (2006) 333-335.
9. V. Torchilin, Antibody-modi.ed liposomes for cancer chemotherapy, Expert Opin Drug Deliv 5 (2008) 1003-1025.
10. S.G. Sampathkumar, K.J. Yarema, Targeting cancer cells with dendrimers, Chem. Biol. 12 (2005) 5-6.
11. Z. Liu, Y. Jiao, Y. Wang, C. Zhou, Z. Zhang, Polysaccharides-based nanoparticles as drug delivery systems, Adv. Drug Deliv. Rev. 60 (2008) 1650-1662.
12. M.N. Kumar, R.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, A.J. Domb, Chitosan chemistry and pharmaceutical perspectives, Chem. Rev. 104 (2004) 6017-6084.
13. L. Illum, Chitosan and its use as a pharmaceutical excipient, Pharm. Res. 15 (1998) 1326-1331.
14. O. Felt, P. Buri, R. Gurny, Chitosan: a unique polysaccharide for drug delivery, Drug. Dev. Ind. Pharm. 24 (1998) 979-993.
15. A. Bernkop-Schnurch, D. Guggi, Y. Pinter, Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system, J. Control Release 94 (2004) 177-186.
16. M. Amidi, S.G. Romeijn, G. Borchard, H.E. Junginger, W.E. Hennink, W. Jiskoot, Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system, J. Control Release 111 (2006) 107-116.
17. Y. Wang, Q. Jiang, R. Li, L. Liu, Q. Zhang, Y. Wang, J. Zhao, Self-assembled nanoparticles of cholesterol-modi.ed O carboxymethyl chitosan as a novel carrier for paclitaxel, Nanotechnology 19 (2008) 145101.
18. J.H. Park, Y.W. Cho, H. Chung, I.C. Kwon, S.Y. Jeong, Synthesis and characterization of sugarbearing chitosan derivatives: aqueous solubility and biodegradability, Biomacromolecules 4 (2003) 1087-1091.
19. A Trapani, M.G. Fuentes, M.J. Alonso, Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan, Nanotechnology 19 (2008) 185101.
20. K. Kim, S. Kwon, J.H. Park, H. Chung, S.Y. Jeong, I.C. Kwon, I.S. Kim, Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates, Biomacromolecules 6 (2005) 1154-1158.
21. K. Kurita, Chitin and chitosan: functional biopolymers from marine crustaceans, Mar. Biotechnol. (NY) 8 (2006) 203-226.
22. V.K. Mourya, N.N. Inamdar, Chitosan-modi.cations and applications: opportunities galore, React. Funct. Polym. 68 (2008) 1013-1051.
23. V.M. Leitner, G.F. Walker, A. Bernkop-Schnurch, Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins, Eur. J. Pharm. Biopharm. 56 (2003) 207-214.
24. C. Dufes, J.M. Muller, W. Couet, J.C. Olivier, I.F. Uchegbu, A.G. Schatzlein, Anticancer drug delivery with transferrin targeted polymeric chitosan vesicles, Pharm. Res. 21 (2004) 101-107.
25. J.H. Kim, Y.S. Kim, K. Park, S. Lee, H.Y. Nam, K.H. Min, H.G. Jo, J.H. Park, K. Choi, S.Y. Jeong, R.W. Park, I.S. Kim, K. Kim, I.C. Kwon, Antitumor ef.cacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice, J. Control Release 127 (2008) 41-49.
26. H.S. Yoo, J.E. Lee, H. Chung, I.C. Kwon, S.Y. Jeong, Self-assembled nanoparticles containing hydrophobically modi.ed glycol chitosan for gene delivery, J. Control Release 103 (2005) 235-243.
27. J.P. Overington, B. Al-Lazikani, A.L. Hopkins, How many drug targets are there? Nat. Rev. Drug Discov. 5 (2006) 993-996.
28. M.K. Chourasia, S.K. Jain, Polysaccharides for colon targeted drug delivery, Drug Deliv. 11 (2004) 129-148.
29. S.K. Jain, A. Jain, Target-specificdrug release to the colon, Expert. Opin. Drug Deliv. 5 (2008) 483-498.
30. R. Hejazi, M. Amiji, Chitosan-based gastrointestinal delivery systems, J. Control Release 89 (2003) 151-165.
31. H. Tozaki, J. Komoike, C. Tada, T. Maruyama, A. Terabe, T. Suzuki, A. Yamamoto, S. Muranishi, Chitosan capsules for colon-specificdrug delivery: improvement of insulin absorption from the rat colon, J. Pharm. Sci. 86 (1997) 1016-1021.
32. H. Tozaki, T. Odoriba, N. Okada, T. Fujita, A. Terabe, T. Suzuki, S. Okabe, S. Muranishi, A. Yamamoto, Chitosan capsules for colonspecificdrug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats, J. Control Release 82 (2002) 51-61.
33. G. Fetih, S. Lindberg, K. Itoh, N. Okada, T. Fujita, F. Habib, P. Artersson, M. Attia, A. Yamamoto, Improvement of absorption enhancing effects of ndodecyl- beta-Dmaltopyranoside by its colonspecificdelivery using chitosan capsules, Int. J. Pharm. 293 (2005) 127-135.
34. J. Varshosaz, A. Jaffarian Dehkordi, S. Golafshan, Colon-specificdelivery of mesalazine chitosan microspheres, J. Microencapsul. 23 (2006) 329-339.
35. K. Mladenovska, R.S. Raicki, E.I. Janevik, T. Ristoski, M.J. Pavlova, Z. Kavrakovski, M.G. Dodov, K. Goracinova, Colon-specificdelivery of 5- aminosalicylic acid from chitosan-Ca-alginate microparticles, Int. J. Pharm. 342 (2007) 124-136.
36. S.K. Jain, A. Jain, Y. Gupta, A. Jain, P. Khare, M. Kannandasan, Targeted delivery of 5-ASA to colon using chitosan hydrogel microspheres, J. Drug Deliv. Sci. Tech. 18 (2008) 315-321.
37. M.L. Lorenzo-Lamosa, C. Remunan-Lopez, J.L. Vila-Jato, M.J. Alonso, Design of microencapsulated chitosan microspheres for colonic drug delivery, J. Control Release 52 (1998) 109-118.
38. T. Oosegi, H. Onishi, Y. Machida, Novel preparation of enteric-coated chitosan- prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system, Eur. J. Pharm. Biopharm. 68 (2008) 260-266.
39. S.K. Jain, A. Jain, Y. Gupta, M. Ahirwar, Design and development of hydrogel beads for targeted drug delivery to the colon, AAPS PharmSciTech 8 (2007) E56.
40. M.K. Chourasia, S.K. Jain, Design and development of multiparticulate system for targeted drug delivery to colon, Drug Deliv. 11 (2004) 201-207.
41. A.A. Elzatahry, M.S.M. Eldin, Preparation and characterization of metronidazole loaded chitosan nanoparticles for drug delivery application, Polym. Adv. Technol. 19 (2008) 1787-1791.
42. A. Jain, S.K. Jain, In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors, Eur. J. Pharm. Sci. 35 (2008) 404-416.
43. K. Ogawara, M. Yoshida, K. Higaki, T. Kimura, K. Shiraishi, M. Nishikawa, Y. Takakura, M. Hashida, Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution, J. Control Release 59 (1999) 15-22.
44. Y. Kato, H. Onishi, Y. Machida, Biological characteristics of lactosaminated Nsuccinylchitosan as a liver-specificdrug carrier inmice, J. Control Release 70 (2001) 295-307.
45. Y. Kato, H. Onishi, Y. Machida, Ef.cacy of lactosaminated and intact Nsuccinylchitosan - mitomycin C conjugates against M5076 liver metastatic cancer, J. Pharm. Pharmacol. 54 (2002) 529-537.
46. K.W. Yang, X.R. Li, Z.L. Yang, P.Z. Li, F. Wang, Y. Liu, Novel polyion complex micelles for livertargeted delivery of diammonium glycyrrhizinate: in vitro and in vivo characterization, J. Biomed. Mater. Res. A. 88 (2009) 140-148.
47. A. Lin, Y. Liu, Y. Huang, J. Sun, Z. Wu, X. Zhang, Q. Ping, Glycyrrhizin surfacemodified chitosan nanoparticles for hepatocyte-targeted delivery, Int. J. Pharm. 359 (2008) 247-253.
48. R. Vriesendorp, A.J. Donker, D. de Zeeuw, P.E. de Jong, G.K. van der Hem, J.R. Brentjens, Effects of nonsteroidal anti-in.ammatory drugs on proteinuria, Am. J. Med. 81 (1986) 84-94.
49. K. Suzuki, H. Susaki, S. Okuno, Y. Sugiyama, Renal drug targeting using a vector, alkylglycoside, J. Pharmacol. Exp. Ther. 288 (1999) 57-64.
50. S. Wilk, H. Mizoguchi, M. Orlowski, Gammaglutamyl dopa: a kidney-speci.c dopamine precursor, J. Pharmacol. Exp. Ther. 206 (1978) 227-232.
51. M. Haas, A.C. Kluppel, E.S. Wartna, F. Moolenaar, D.K. Meijer, P.E. de Jong, D. De Zeeuw, Drugtargeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo, Kidney Int. 52 (1997) 1693-1699.
52. H. Kodaira, Y. Tsutsumi, Y. Yoshioka, H. Kamada, Y. Kaneda, Y. Yamamoto, S. Tsunoda, T. Okamoto, Y. Mukai, H. Shibata, S. Nakagawa, T. Mayumi, The targeting of anionized polyvinylpyrrolidone to the renal system, Biomaterials 25 (2004) 4309-4315.
53. H. Onishi, Y. Machida, Biodegradation and distribution of water-soluble chitosan in mice, Biomaterials 20 (1999) 175-182.
54. Z.X. Yuan, X. Sun, T. Gong, H. Ding, Y. Fu, Z.R. Zhang, Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier, J. Drug Target 15 (2007) 269-278.
55. Z.X. Yuan, Z.R. Zhang, D. Zhu, X. Sun, T. Gong, J. Liu, C.T. Luan, Specificrenal uptake of randomly 50% N-acetylated low molecular weight chitosan, Mol. Pharm. 6 (2009) 305-314.
56. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M.J. Thun, Cancer statistics, 2008, CA Cancer J. Clin. 58 (2008) 71-96.
57. H.M. Courrier, N. Butz, T.F. Vandamme, Pulmonary drug delivery systems: recent developments and prospects, Crit. Rev. Ther. Drug Carrier Syst. 19 (2002) 425-498.
58. K. Saralidze, C.S. van Hooy-Corstjens, L.H. Koole, M.L. Knetsch, New acrylic microspheres for arterial embolization: combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation, Biomaterials 28 (2007) 2457-2464.
59. D.R. Klonne, D.E. Dodd, P.E. Losco, C.M. Troup, T.R. Tyler, Pulmonary. brosis produced in F-344 rats by subchronic inhalation of aerosols of a 4000 molecular weight ethylene oxide/propylene oxide polymer, Fundam. Appl. Toxicol. 10 (1988) 682-690.
60. R. Yang, S.G. Yang, W.S. Shim, F. Cui, G. Cheng, I.W. Kim, D.D. Kim, S.J. Chung, C.K. Shim, Lungspecificdelivery of paclitaxel by chitosan-modi.ed PLGA nanoparticles via transient formation of microaggregates, J. Pharm. Sci. 98 (2009) 970-984.
61. R. Yang, W.S. Shim, F.D. Cui, G. Cheng, X. Han, Q.R. Jin, D.D. Kim, S.J. Chung, C.K. Shim, Enhanced electrostatic interaction between chitosanmodi. ed PLGA nanoparticle and tumor, Int. J. Pharm. 371 (2009) 142-147.
62. V.P. Torchilin, Targeted polymeric micelles for delivery of poorly soluble drugs, Cell. Mol. Life Sci. 61 (2004) 2549-2559.
63. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res. 46 (1986) 6387-6392.
64. H. Maeda, The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting, Adv. Enzyme Regul. 41 (2001) 189-207.
65. H. Ringsdorf, Structure and properties of pharmacologically active polymers, J. Polym. Sci. Polym. Symp. 51 (1975) 135-153.
66. L.W. Seymour, K. Ulbrich, S.R. Wedge, I.C. Hume, J. Strohalm, R. Duncan, N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactosereceptor: pharmacokinetics in DBA2 mice, Br. J. Cancer 63 (1991) 859-866.
67. Y.J. Son, J.S. Jang, Y.W. Cho, H. Chung, R.W. Park, I.C. Kwon, I.S. Kim, J.Y. Park, S.B. Seo, C.R. Park, S.Y. Jeong, Biodistribution and anti-tumor ef.cacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect, J. Control Release 91 (2003) 135-145.
68. E. Lee, J. Lee, I.H. Lee, M. Yu, H. Kim, S.Y. Chae, S. Jon, Conjugated chitosan as a novel platform for oral delivery of paclitaxel, J. Med. Chem. 51 (2008) 6442-6449.
69. Y. Song, H. Onishi, T. Nagai, Synthesis and drugrelease characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethyl-chitin, Chem Pharm Bull (Tokyo) 40 (1992) 2822-2825.
70. Y. Kato, H. Onishi, Y. Machida, N-succinylchitosan as a drug carrier: waterinsoluble and watersoluble conjugates, Biomaterials 25 (2004) 907-915.
71. M. Prabaharan, J.F. Mano, Chitosan-based particles as controlled drug delivery systems, Drug Deliv. 12 (2005) 41-57.
72. M. Goldberg, R. Langer, X. Jia, Nanostructured materials for applications in drug delivery and tissue engineering, J. Biomater. Sci. Polym. Ed. 18 (2007) 241-268.
73. M. Bodnar, J.F. Hartmann, J. Borbely, Preparation and characterization of chitosan-based nanoparticles, Biomacromolecules 6 (2005) 2521-2527.
74. Y. Ohya, M. Shiratani, H. Kobayashi, T. Ouchi, Release behavior of 5-.uorouracil from chitosan-gel nanospheres immobilizing 5-.uorouracil coated with polysaccharides and their cell specificcytotoxicity, Pure Appl. Chem. A31 (1994) 629-642.
75. P. Calvo, C. Remunan-Lopez, J.L. Vila-Jato, M.J. Alonso, Chitosan and chitosan/ ethylene oxidepropylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines, Pharm. Res. 14 (1997) 1431-1436.
76. S.A. Agnihotri, N.N. Mallikarjuna, T.M. Aminabhavi, Recent advances on chitosanbasedmicro- and nanoparticles in drug delivery, J. Control Release 100 (2004) 5-28.
77. S. Mitra, U. Gaur, P.C. Ghosh, A.N. Maitra, Tumour targeted delivery of encapsulated dextran- doxorubicin conjugate using chitosan nanoparticles as carrier, J. Control Release 74 (2001) 317-323.
78. R. Bodmeier, H.G. Chen, O. Paeratakul, A novel approach to the oral delivery of micro- or nanoparticles, Pharm. Res. 6 (1989) 413-417.
79. K.A. Janes, M.P. Fresneau, A. Marazuela, A. Fabra, M.J. Alonso, Chitosan nanoparticles as delivery systems for doxorubicin, J. Control Release 73 (2001) 255-267.
80. W. Sun, S. Mao, D. Mei, T. Kissel, Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin, Eur. J. Pharm. Biopharm. 69 (2008) 417-425.
81. W. Liu, S. Sun, Z. Cao, X. Zhang, K. Yao, W.W. Lu, K.D. Luk, An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes, Biomaterials 26 (2005) 2705-2711.
82. A.V. Il'ina, V.P. Varlamov, Chitosan-based polyelectrolyte complexes: a review, Prikl. Biokhim. Mikrobiol. 41 (2005) 9-16.
83. A. Drogoz, L. David, C. Rochas, A. Domard, T. Delair, Polyelectrolyte complexes from polysaccharides: formation and stoichiometry monitoring, Langmuir 23 (2007) 10950-10958.
84. A. Denuziere, D. Ferrier, O. Damour, A. Domard, Chitosan-chondroitin sulfate and chitosan- hyaluronate polyelectrolyte complexes: biological properties, Biomaterials 19 (1998) 1275-1285.
85. C.L. de Vasconcelos, P.M. Bezerril, D.E. dos Santos, T.N. Dantas, M.R. Pereira, J.L. Fonseca, Effect of molecular weight and ionic strength on the formation of polyelectrolyte complexes based on poly(methacrylic acid) and chitosan, Biomacromolecules 7 (2006) 1245-1252.
86. Y. Hu, X. Jiang, Y. Ding, H. Ge, Y. Yuan, C. Yang, Synthesis and characterization of chitosan-poly(acrylic acid) nanoparticles, Biomaterials 23 (2002) 3193-3201.
87. Y. Zheng, W. Yang, C. Wang, J. Hu, S. Fu, L. Dong, L. Wu, X. Shen, Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: preparation, characterization and the use for 5-.uorouracil delivery, Eur. J. Pharm. Biopharm. 67 (2007) 621-631.
88. D.Y. Zhang, X.Z. Shen, J.Y. Wang, L. Dong, Y.L. Zheng, L.L. Wu, Preparation of chitosan-polyaspartic acid-5-.uorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nudemice, World J.Gastroenterol. 14 (2008) 3554-3562.
89. S. Cafaggi, E. Russo, R. Stefani, R. Leardi, G. Caviglioli, B. Parodi, G. Bignardi, D. De Totero, C. Aiello, M. Viale, Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex, J. Control Release 121 (2007) 110-123.
90. X. Cheng, F. Zhang, G. Zhou, S. Gao, L. Dong, W. Jiang, Z. Ding, J. Chen, J. Zhang, DNA/chitosan nanocomplex as a novel drug carrier for doxorubicin, Drug Deliv. 16 (2009) 135-144.
91. Y. Hu, Y. Ding, D. Ding, M. Sun, L. Zhang, X. Jiang, C. Yang, Hollow chitosan/poly (acrylic acid) nanospheres as drug carriers, Biomacromolecules 8 (2007) 1069-1076.
92. Z. Keresztessy, M. Bodnár, E. Ber, I. Hajdu, M. Zhang, J.F. Hartmann, T. Minko, J. Borbély, Selfassembling chitosan/poly-ã-glutamic acid nanoparticles for targeted drug delivery, Colloid Polym. Sci. 287 (2009) 759-765.
93. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, R. Langer, Biodegradable long-circulating polymeric nanospheres, Science 263 (1994) 1600-1603.
94. S.M. Moghimi, A.C. Hunter, J.C. Murray, Longcirculating and target-specific nanoparticles: theory to practice, Pharmacol. Rev. 53 (2001) 283-318.
95. J.H. Kim, Y.S. Kim, S. Kim, J.H. Park, K. Kim, K. Choi, H. Chung, S.Y. Jeong, R.W. Park, I.S. Kim, I.C. Kwon, Hydrophobically modi.ed glycol chitosan nanoparticles as carriers for paclitaxel, J. Control Release 111 (2006) 228-234.
96. K.H. Min, K. Park, Y.S. Kim, S.M. Bae, S. Lee, H.G. Jo, R.W. Park, I.S. Kim, S.Y. Jeong, K. Kim, I.C. Kwon, Hydrophobically modi.ed glycol chitosan nanoparticlesencapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy, J. Control Release 127 (2008) 208-218.
97. H.Y. Hwang, I.S. Kim, I.C. Kwon, Y.H. Kim, Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modi.ed glycol chitosan nanoparticles, J. Control Release 128 (2008) 23-31.
98. J. Zhang, X.G. Chen, Y.Y. Li, C.S. Liu, Selfassembled nanoparticles based on hydrophobically modi.ed chitosan as carriers for doxorubicin, Nanomedicine 3 (2007) 258-265.
99. G.B. Jiang, D. Quan, K. Liao, H. Wang, Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery, Mol. Pharm. 3 (2006) 152-160.
100. Y.Q. Ye, F.L. Yang, F.Q. Hu, Y.Z. Du, H. Yuan, H.Y. Yu, Core-modi.ed chitosan-based polymeric micelles for controlled release of doxorubicin, Int. J. Pharm. 352 (2008) 294-301.
101. K.Y. Lee, J.-H. Kim, I.C. Kwon, S.Y. Jeong, Selfaggregates of deoxycholic acidmodi. ed chitosan as a novel carrier of adriamycin, Colloid Polym. Sci. 278 (2000) 1216-1219.
102. T. Ngawhirunpat, N. Wonglertnirant, P. Opanasopit, U. Ruktanonchai, R. Yoksan, K. Wasanasuk, S. Chirachanchai, Incorporation methods for cholic acid chitosang- mPEG self-assembly micellar system containing camptothecin, Colloids Surf. B., Biointerfaces 74 (2009) 253-259.
103. S. Kwon, J.H. Park, H. Chung, I.C. Kwon, S.Y. Jeong, Physicochemical characteristics of selfassembled nanoparticles based on glycol chitosan bearing 5bcholanic acid, Langmuir 19 (2003) 10188-10193.
104. C. Zhang, Q. Ping, H. Zhang, J. Shen, Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol, Carbohyd. Polym. 54 (2003) 137-141.
105. C. Zhang, P. Qineng, H. Zhang, Self-assembly and characterization of paclitaxelloaded N-octyl-Osulfate chitosan micellar system, Colloids Surf. B., Biointerfaces 39 (2004) 69-75.
106. C. Zhang, G. Qu, Y. Sun, T. Yang, Z. Yao, W. Shen, Z. Shen, Q. Ding, H. Zhou, Q. Ping, Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs, Eur. J. Pharm. Sci. 33 (2008) 415-423.
107. Y.S. Wang, L.R. Liu, Q. Jiang, Q.Q. Zhang, Selfaggregated nanoparticles of cholesterol-modi.ed chitosan conjugate as a novel carrier of epirubicin, Eur. Polym. J. 43 (2007) 43-51.
108. J. You, F.Q. Hu, Y.Z. Du, H. Yuan, Polymeric micelles with glycolipid-like structure and multiple hydrophobic domains for mediating molecular target delivery of paclitaxel, Biomacromolecules 8 (2007) 2450-2456.
109. J. You, F.Q. Hu, Y.Z. Du, H. Yuan, Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosized micelles, Nanotechnology 19 (2008) 255103.
110. F.Q. Hu, X. Wu, Y.Z. Du, J. You, H. Yuan, Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin, Eur. J. Pharm. Biopharm. 69 (2008) 117-125.
111. Y.L. Tan, C.G. Liu, Self-aggregated nanoparticles from linoleic acid modified carboxymethyl chitosan: Synthesis, characterization and application in vitro, Colloids Surf. B., Biointerfaces 69 (2009) 178-182.
112. Z. Zhao, M. He, L. Yin, J. Bao, L. Shi, B. Wang, C. Tang, C. Yin, Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs, Biomacromolecules 10 (2009) 565-572.
113. M. Bodnar, J.F. Hartmann, J. Borbely, Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles, Biomacromolecules 7 (2006) 3030-3036.
114. H. Otsuka, Y. Nagasaki, K. Kataoka, PEGylated nanoparticles for biological and pharmaceutical applications, Adv. Drug Deliv. Rev. 55 (2003) 403-419.
115. J.M. Harris, R.B. Chess, Effect of pegylation on pharmaceuticals, Nat. Rev. Drug Discov. 2 (2003) 214-221.
116. G. Qu, Z. Yao, C. Zhang, X. Wu, Q. Ping, PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation, Eur. J. Pharm. Sci. 37 (2009) 98-105.
117. P. Opanasopit, T. Ngawhirunpat, T. Rojanarata, C. Choochottiros, S. Chirachanchai, Nphthaloylchitosan- g-mPEG design for all-trans retinoic acid-loaded polymeric micelles, Eur. J. Pharm. Sci. 30 (2007) 424-431.
118. Y.I. Jeong, S.H. Kim, T.Y. Jung, I.Y. Kim, S.S. Kang, Y.H. Jin, H.H. Ryu, H.S. Sun, S. Jin, K.K. Kim, K.Y. Ahn, S. Jung, Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan, J. Pharm. Sci. 95 (2006) 2348-2360.
119. P. Opanasopit, T. Ngawhirunpat, A. Chaidedgumjorn, T. Rojanarata, A. Apirakaramwong, S. Phongying, C. Choochottiros, S. Chirachanchai, Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system, Eur. J. Pharm. Biopharm. 64 (2006) 269-276.
120. X. Yang, Q. Zhang, Y. Wang, H. Chen, H. Zhang, F. Gao, L. Liu, Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modi.ed chitosan: synthesis; characterization; aggregation and methotrexate release in vitro, Colloids Surf. B., Biointerfaces 61 (2008) 125-131.
121. J.D. Byrne, T. Betancourt, L. Brannon-Peppas, Active targeting schemes for nanoparticle systems in cancer therapeutics, Adv. Drug Deliv. Rev. 60 (2008) 1615-1626.
122. T.M. Allen, Ligand-targeted therapeutics in anticancer therapy, Nat. Rev. Cancer 2 (2002) 750-763.
123. T.H. Kim, H.L. Jiang, J.W. Nah, M.H. Cho, T. Akaike, C.S. Cho, Receptor-mediated gene delivery using chemically modi.ed chitosan, Biomed. Mater. 2 (2007) S95-100.
124. A.W. Tolcher, S. Sugarman, K.A. Gelmon, R. Cohen, M. Saleh, C. Isaacs, L. Young, D. Healey, N. Onetto, W. Slichenmyer, Randomized phase II study of BR96- doxorubicin conjugate in patients with metastatic breast cancer, J. Clin. Oncol. 17 (1999) 478-484.
125. J. You, X. Li, F. Cui, Y.Z. Du, H. Yuan, F. Hu, Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity, Nanotechnology 19 (2008) 045102.
126. H. Li, Z.M. Qian, Transferrin/transferrin receptormediated drug delivery, Med. Res. Rev. 22 (2002) 225-250.
127. E.M. Kim, H.J. Jeong, I.K. Park, C.S. Cho, C.G. Kim, H.S. Bom, Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution, J. Nucl. Med. 46 (2005) 141-145.
128. C. Zhang, Y. Cheng, G. Qu, X. Wu, Y. Ding, Z. Cheng, Yu Liangli, Q. Ping, Preparation and characterization of galactosylated chitosan coated BSA microspheres containing 5-.uorouracil, Carbohyd. Polym. 72 (2008) 390-397.
129. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, F. Mandelbaum-Shavit, M.M. Qazen, S. Zalipsky, Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies, Bioconjug. Chem. 10 (1999) 289-298.
130. D. Rotin, D. Steele-Norwood, S. Grinstein, I. Tannock, Requirement of the Na+/H+ exchanger for tumor growth, Cancer Res. 49 (1989) 205-211.
131. I.F. Tannock, D. Rotin, Acid pH in tumors and its potential for therapeutic exploitation, Cancer Res. 49 (1989) 4373-4384.
132. T. Yahara, T. Koga, S. Yoshida, S. Nakagawa, H. Deguchi, K. Shirouzu, Relationship between microvessel density and thermographic hot areas in breast cancer, Surg. Today 33 (2003) 243-248.
133. H.C. Hurst, Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment, Breast Cancer Res. 3 (2001) 395-398.
134. M. Stubbs, P.M. McSheehy, J.R. Grifths, Causes and consequences of acidic pH in tumors: a magnetic resonance study, Adv. Enzyme Regul. 39 (1999) 13-30.
135. M. Dellian, G. Helmlinger, F. Yuan, R.K. Jain, Fluorescence ratio imaging of interstitial pH in solid tumours: effect of glucose on spatial and temporal gradients, Br. J. Cancer 74 (1996) 1206-1215.
136. V.A. Sethuraman, M.C. Lee, Y.H. Bae, A biodegradable pH-sensitive micelle system for targeting acidic solid tumors, Pharm. Res. 25 (2008) 657-666.
137. E.S. Lee, Z. Gao, Y.H. Bae, Recent progress in tumor pH targeting nanotechnology, J. Control Release 132 (2008) 164-170.
138. L. Fan, H. Wu, H. Zhang, F. Li, T. Yang, C. Gu, Q. Yang, Novel super pH-sensitive nanoparticles responsive to tumor extracellular pH, Carbohyd. Polym. 73 (2008) 390-400.
139. J.S. Park, T.H. Han, K.Y. Lee, S.S. Han, J.J. Hwang, D.H. Moon, S.Y. Kim, Y.W. Cho, Nacetyl histidine conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release, J. Control Release 115 (2006) 37-45.
140. H. Zhang, S. Mardyani, W.C. Chan, E. Kumacheva, Design of biocompatible chitosan microgels for targeted pH-mediated intracellular release of cancer therapeutics, Biomacromolecules 7 (2006) 1568-1572.
141. Q.A. Pankhurst, J. Connolly, S.K. Jones, J. Dobson, Applications of magnetic nanoparticles in biomedicine, J. Phys. D: Appl. Phys. 36 (2003) R167-R181.
142. E.E. Hassan, J.M. Gallo, Targeting anticancer drugs to the brain. I: enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres, J. Drug Target 1 (1993) 7-14.
143. L. Zhu, J. Ma, N. Jia, Y. Zhao, H. Shen, Chitosancoated magnetic nanoparticles as carriers of 5-.uorouracil: preparation, characterization and cytotoxicity studies, Colloids Surf. B., Biointerfaces 68 (2009) 1-6.
144. Y.C. Chang, D.B. Shieh, C.H. Chang, D.H. Chen, Conjugation of monodisperse chitosan-bound magnetic nanocarrier with epirubicin for targeted cancer therapy, J. Biomed. Nanotech. 1 (2005) 196-201.
145. Q. Yuan, R. Venkatasubramanian, S. Hein, R.D. Misra, A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosangrafted- copolymer, Acta Biomater. 4 (2008) 1024-1037.